ES2067541T3 - Mejoras en antagonistas de la serotonina y relacionadas con ellos. - Google Patents
Mejoras en antagonistas de la serotonina y relacionadas con ellos.Info
- Publication number
- ES2067541T3 ES2067541T3 ES89305516T ES89305516T ES2067541T3 ES 2067541 T3 ES2067541 T3 ES 2067541T3 ES 89305516 T ES89305516 T ES 89305516T ES 89305516 T ES89305516 T ES 89305516T ES 2067541 T3 ES2067541 T3 ES 2067541T3
- Authority
- ES
- Spain
- Prior art keywords
- serotonine
- antagonists
- serotonine antagonists
- aryloxypropanolamines
- mammals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
- C07C209/06—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms
- C07C209/08—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of halogen atoms with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
ESTA INVENCION SE REFIERE A UN METODO PARA ANTAGONIZAR SELECTIVAMENTE AL RECEPTOR DE 5 - HT1 EN MAMIFEROS, MEDIANTE ADMINISTRACION DE ARILOXIPROPANOLAMINAS. TAMBIEN SE REIVINDICAN NUEVAS ARILOXIPROPANOLAMINAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20276788A | 1988-06-03 | 1988-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2067541T3 true ES2067541T3 (es) | 1995-04-01 |
Family
ID=22751177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89305516T Expired - Lifetime ES2067541T3 (es) | 1988-06-03 | 1989-06-01 | Mejoras en antagonistas de la serotonina y relacionadas con ellos. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0345056B1 (es) |
JP (2) | JP2806555B2 (es) |
KR (1) | KR0132779B1 (es) |
CN (1) | CN1023402C (es) |
AT (1) | ATE117980T1 (es) |
CA (1) | CA1336911C (es) |
DE (1) | DE68920913T2 (es) |
DK (1) | DK271889A (es) |
ES (1) | ES2067541T3 (es) |
GR (1) | GR3015297T3 (es) |
HU (1) | HUT56056A (es) |
IE (1) | IE66225B1 (es) |
IL (1) | IL90498A (es) |
NZ (1) | NZ229376A (es) |
PT (1) | PT90716B (es) |
RU (1) | RU1795965C (es) |
ZA (1) | ZA894145B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5340838A (en) * | 1990-05-04 | 1994-08-23 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines |
US5096908A (en) * | 1990-05-04 | 1992-03-17 | Eli Lilly And Company | Method of inhibiting gastric acid secretion |
US5258379A (en) * | 1990-05-04 | 1993-11-02 | Eli Lilly And Company | Method of inhibiting gastric acid secretion with n-arylpiperazines |
IL110857A0 (en) * | 1993-09-09 | 1994-11-28 | Lilly Co Eli | Cessation of tobacco use |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
US5808080A (en) | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
CO5011072A1 (es) * | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
FR2817257B1 (fr) | 2000-11-30 | 2009-03-20 | Sanofi Synthelabo | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant |
FR2840301B1 (fr) * | 2002-05-29 | 2007-03-23 | Sanofi Synthelabo | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3471515A (en) * | 1965-02-01 | 1969-10-07 | Sandoz Ag | (2-hydroxy-3-substituted aminopropoxy)indoles |
DE1668055B2 (de) * | 1967-03-10 | 1973-09-06 | Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt | Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung |
US5229412A (en) * | 1988-03-25 | 1993-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Method for relieving anxiety using 5-hydroxytryptamine-1a-receptor-binding compounds |
-
1989
- 1989-06-01 ES ES89305516T patent/ES2067541T3/es not_active Expired - Lifetime
- 1989-06-01 DE DE68920913T patent/DE68920913T2/de not_active Expired - Fee Related
- 1989-06-01 IL IL9049889A patent/IL90498A/en not_active IP Right Cessation
- 1989-06-01 CN CN89103839A patent/CN1023402C/zh not_active Expired - Fee Related
- 1989-06-01 EP EP89305516A patent/EP0345056B1/en not_active Expired - Lifetime
- 1989-06-01 PT PT90716A patent/PT90716B/pt not_active IP Right Cessation
- 1989-06-01 JP JP1140240A patent/JP2806555B2/ja not_active Expired - Fee Related
- 1989-06-01 NZ NZ229376A patent/NZ229376A/en unknown
- 1989-06-01 RU SU894614121A patent/RU1795965C/ru active
- 1989-06-01 CA CA000601438A patent/CA1336911C/en not_active Expired - Fee Related
- 1989-06-01 AT AT89305516T patent/ATE117980T1/de active
- 1989-06-01 ZA ZA894145A patent/ZA894145B/xx unknown
- 1989-06-02 HU HU892827A patent/HUT56056A/hu unknown
- 1989-06-02 KR KR1019890007568A patent/KR0132779B1/ko not_active IP Right Cessation
- 1989-06-02 DK DK271889A patent/DK271889A/da not_active Application Discontinuation
- 1989-06-12 IE IE181189A patent/IE66225B1/en unknown
-
1995
- 1995-03-03 GR GR950400475T patent/GR3015297T3/el unknown
-
1998
- 1998-03-16 JP JP10065275A patent/JP3050844B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IE66225B1 (en) | 1995-12-13 |
PT90716A (pt) | 1989-12-29 |
EP0345056A3 (en) | 1992-07-01 |
KR0132779B1 (ko) | 1998-04-13 |
DK271889D0 (da) | 1989-06-02 |
JPH10273437A (ja) | 1998-10-13 |
AU3601989A (en) | 1989-12-07 |
NZ229376A (en) | 1991-07-26 |
ZA894145B (en) | 1991-02-27 |
KR910000599A (ko) | 1991-01-29 |
EP0345056A2 (en) | 1989-12-06 |
RU1795965C (ru) | 1993-02-15 |
IE891811L (en) | 1989-12-03 |
CN1023402C (zh) | 1994-01-05 |
IL90498A (en) | 1995-12-08 |
JP2806555B2 (ja) | 1998-09-30 |
JP3050844B2 (ja) | 2000-06-12 |
DE68920913D1 (de) | 1995-03-16 |
AU609997B2 (en) | 1991-05-09 |
EP0345056B1 (en) | 1995-02-01 |
HUT56056A (en) | 1991-07-29 |
PT90716B (pt) | 1995-03-01 |
DE68920913T2 (de) | 1995-06-22 |
GR3015297T3 (en) | 1995-06-30 |
JPH0225416A (ja) | 1990-01-26 |
DK271889A (da) | 1989-12-05 |
ATE117980T1 (de) | 1995-02-15 |
CN1045774A (zh) | 1990-10-03 |
CA1336911C (en) | 1995-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033308D1 (de) | Decahydro-isochinolin-derivate | |
ATE106401T1 (de) | Benzodiazepin-analoge. | |
ATE195553T1 (de) | Kristallisierung von m-csf | |
SE8400788D0 (sv) | Novel adenosine receptor antagonists | |
GR1001129B (el) | Ανταγωνιστες ccκ αναλογου αμινοξεος. | |
ES2067541T3 (es) | Mejoras en antagonistas de la serotonina y relacionadas con ellos. | |
DK530888D0 (da) | Leukotrien -ltd4- og - ltb4-antagonister | |
ATE87918T1 (de) | Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren. | |
DE3851366D1 (de) | Digitaler Generator von Konturlinien. | |
DK430689D0 (da) | 2-aza-4-(alkoxycarbonyl)spiro(4,5)decan-3-oner | |
IT8948551A0 (it) | Procedimento per la produzione di analgesia in mammiferi. | |
ZA894097B (en) | Alpha-adrenergic receptor antagonists | |
DK652788A (da) | Glycoprotein | |
DK286090D0 (da) | Alfa-adrenerge receptorantagonister | |
DK525787D0 (da) | Polypeptidantagonister | |
KR890002712U (ko) | 엘리베이터의 직접식 조속기 | |
DE69004827D1 (de) | Alpha-adrenergene Rezeptor-Antagonisten. | |
IT8622736A0 (it) | Antagonisti dell'aldosterone. | |
SE8703284D0 (sv) | Justerbar sittpall for jordgubbsplockning m m kallad for plocka-lett | |
BR6700648U (pt) | Gaseificador de madeira | |
ES554226A0 (es) | Merjoras en el objeto de la patente principal n 548.447 por prefeccionamientos en la construccion de pantografos mecanicos | |
KR880004579U (ko) | 엘리베이터의 높낮이 조정용 완충대 | |
RO95125A2 (ro) | Boghiu-motor pentru tramvaie | |
IT1222146B (it) | Struttura precaria per la realizzazione di zone attrezzate particolarmente per manifestazioni sportive | |
SE8604143D0 (sv) | Kolforsedd bat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 345056 Country of ref document: ES |